已收盤 11-14 16:00:00 美东时间
+1.320
+3.35%
Piper Sandler analyst Ryan Todd maintains Delek US Hldgs (NYSE:DK) with a Neutral and raises the price target from $39 to $47.
11-14 23:42
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Delek业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **第三季度核心财务表现:** - **调整后每股收益(EPS)**:1.52美元(剔除SRE影响) - **调整后EBITDA**:约3.19亿美元(剔除SRE影响);总调整后EBITDA约7.6亿美元 - **净利润**:1.78亿美元(2.93美元/股) - **调整后净利润**:4.34亿美元(7.13美元/股) - **调整后炼油利润率**:6.886亿美元(包含SRE收益) - **经营现金流**:4400万美元;调整工作资本后为1.5亿美元 **分部门业绩:**
11-08 12:04
Delek US Holdings shares are trading higher after the company reported better-t...
11-07 21:42
Delek US Hldgs (NYSE:DK) reported quarterly sales of $2.887 billion which beat the analyst consensus estimate of $2.763 billion by 4.49 percent. This is a 5.10 percent decrease over sales of $3.042 billion the same
11-07 19:36
Companies Reporting Before The Bell • Kiora Pharmaceuticals (NASDAQ:KPRX) is pr...
11-07 19:11
Delek Logistics Partners (DKL) is scheduled to announce Q3 earnings results on Friday, November 7th, before market open. The consensus EPS Estimate is $1.04 and the consensus Revenue Estimate is $253....
11-06 23:05
在媒介碎片化、需求个性化的新消费时代,品牌增长的密码已从“渠道为王”转向“心智为王”。 对于品牌而言,这是挑战更是机遇。在当前人口结构深刻变化的时代,一方面,随...
10-30 17:35
Kepler Capital analyst Axel Styrman maintained a Buy rating on D/S Norden A/S o...
10-30 09:49